Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2019, Article ID 5689465, 14 pages
https://doi.org/10.1155/2019/5689465
Research Article

Systemic Resolvin E1 (RvE1) Treatment Does Not Ameliorate the Severity of Collagen-Induced Arthritis (CIA) in Mice: A Randomized, Prospective, and Controlled Proof of Concept Study

1Department of Diagnosis and Surgery, School of Dentistry at Araraquara, Sao Paulo State University-UNESP, Araraquara, SP, Brazil
2Department of Rheumatology, Radboud University Medical Center, 6500 HB Nijmegen, Netherlands

Correspondence should be addressed to Rafael Scaf de Molon; rb.psenu@nolom.leafar

Received 17 April 2019; Revised 17 July 2019; Accepted 3 September 2019; Published 31 October 2019

Guest Editor: Bernd Uhl

Copyright © 2019 Rafael Scaf de Molon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Scott, F. Wolfe, and T. W. Huizinga, “Rheumatoid arthritis,” The Lancet, vol. 376, no. 9746, pp. 1094–1108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. Queiroz-Junior, M. F. M. Madeira, F. M. Coelho et al., “Experimental arthritis triggers periodontal disease in mice: involvement of TNF-α and the oral microbiota,” Journal of Immunology, vol. 187, no. 7, pp. 3821–3830, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. G. S. Firestein and I. B. McInnes, “Immunopathogenesis of rheumatoid arthritis,” Immunity, vol. 46, no. 2, pp. 183–196, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. G. S. Firestein, “Evolving concepts of rheumatoid arthritis,” Nature, vol. 423, no. 6937, pp. 356–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. Edwards and C. Cooper, “Early environmental factors and rheumatoid arthritis,” Clinical and Experimental Immunology, vol. 143, no. 1, pp. 1–5, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Hutchinson and R. Moots, “Cigarette smoking and severity of rheumatoid arthritis,” Rheumatology, vol. 40, no. 12, pp. 1426-1427, 2001. View at Publisher · View at Google Scholar
  7. H. Källberg, L. Padyukov, R. M. Plenge et al., “Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis,” American Journal of Human Genetics, vol. 80, no. 5, pp. 867–875, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. Gravallese, Y. Harada, J. T. Wang, A. H. Gorn, T. S. Thornhill, and S. R. Goldring, “Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis,” The American Journal of Pathology, vol. 152, no. 4, pp. 943–951, 1998. View at Google Scholar
  9. A. Gough, P. Sambrook, J. Devlin et al., “Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis,” The Journal of Rheumatology, vol. 25, no. 7, pp. 1282–1289, 1998. View at Google Scholar
  10. Y. Tanaka, “Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside,” The Journal of Biochemistry, vol. 158, no. 3, pp. 173–179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. C. N. Serhan, “Pro-resolving lipid mediators are leads for resolution physiology,” Nature, vol. 510, pp. 92–101, 2014. View at Google Scholar
  12. C. N. Serhan, N. Chiang, and T. E. Van Dyke, “Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators,” Nature Reviews Immunology, vol. 8, no. 5, pp. 349–361, 2008. View at Google Scholar
  13. T. E. Van Dyke, “The management of inflammation in periodontal disease,” Journal of Periodontology, vol. 79, pp. 1601–1608, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. F. C. Fonseca, R. M. Orlando, R. M. Turchetti-Maia, and J. N. de Francischi, “Comparative effects of the ω3 polyunsaturated fatty acid derivatives resolvins E1 and D1 and protectin DX in models of inflammation and pain,” Journal of Inflammation Research, vol. 10, pp. 119–133, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Z. Xu, L. Zhang, T. Liu et al., “Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions,” Nature Medicine, vol. 16, no. 5, pp. 592–597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Hasturk, A. Kantarci, E. Goguet-Surmenian et al., “Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo,” Journal of Immunology, vol. 179, no. 10, pp. 7021–7029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Hasturk, A. Kantarci, T. Ohira et al., “RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis,” The FASEB Journal, vol. 20, no. 2, pp. 401–403, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Fredman, S. F. Oh, S. Ayilavarapu, H. Hasturk, C. N. Serhan, and T. E. Van Dyke, “Impaired phagocytosis in localized aggressive periodontitis: rescue by resolvin E1,” PLoS One, vol. 6, no. 9, p. e24422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. T. Lee, R. Teles, A. Kantarci et al., “Resolvin E1 reverses experimental periodontitis and dysbiosis,” The Journal of Immunology, vol. 197, no. 7, pp. 2796–2806, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Gao, D. Faibish, G. Fredman et al., “Resolvin E1 and chemokine-like receptor 1 mediate bone preservation,” The Journal of Immunology, vol. 190, no. 2, pp. 689–694, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Huang, J. J. Burston, L. Li et al., “Targeting the D series resolvin receptor system for the treatment of osteoarthritis pain,” Arthritis & Rheumatology, vol. 69, no. 5, pp. 996–1008, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Canny, O. Levy, G. T. Furuta et al., “Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 6, pp. 3902–3907, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Hessen and E. K. Akpek, “Dry eye: an inflammatory ocular disease,” Journal of Ophthalmic & Vision Research, vol. 9, no. 2, pp. 240–250, 2014. View at Google Scholar
  24. P. de Pablo, I. L. Chapple, C. D. Buckley, and T. Dietrich, “Periodontitis in systemic rheumatic diseases,” Nature Reviews Rheumatology, vol. 5, no. 4, pp. 218–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. S. de Molon, C. Rossa Jr., R. M. Thurlings, J. A. Cirelli, and M. I. Koenders, “Linkage of periodontitis and rheumatoid arthritis: current evidence and potential biological interactions,” International Journal of Molecular Sciences, vol. 20, no. 18, p. 4541, 2019. View at Publisher · View at Google Scholar
  26. C. Kilkenny, W. J. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman, “Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research,” Osteoarthritis and Cartilage, vol. 20, no. 4, pp. 256–260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. D. M. Roeleveld, R. J. Marijnissen, B. Walgreen et al., “Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis,” PLoS One, vol. 12, no. 2, p. e0171757, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. L. A. Joosten, M. M. Helsen, F. A. van de Loo, and W. B. van den Berg, “Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra,” Arthritis and Rheumatism, vol. 39, no. 5, pp. 797–809, 1996. View at Google Scholar
  29. W. B. van den Berg, L. A. Joosten, M. Helsen, and F. A. van de Loo, “Amelioration of established murine collagen‐induced arthritis with anti‐IL‐1 treatment,” Clinical and Experimental Immunology, vol. 95, no. 2, pp. 237–243, 1994. View at Publisher · View at Google Scholar
  30. S. G. de Aquino, S. Abdollahi-Roodsaz, M. I. Koenders et al., “Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1–driven Th17 response,” Journal of Immunology, vol. 192, no. 9, pp. 4103–4111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Rogier, T. H. A. Ederveen, J. Boekhorst et al., “Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis,” Microbiome, vol. 5, no. 1, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. R. S. de Molon, C. Hsu, O. Bezouglaia et al., “Rheumatoid arthritis exacerbates the severity of osteonecrosis of the jaws (ONJ) in mice. A randomized, prospective, controlled animal study,” Journal of Bone and Mineral Research, vol. 31, no. 8, pp. 1596–1607, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. B. S. Herrera, T. Ohira, L. Gao et al., “An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption,” British Journal of Pharmacology, vol. 155, no. 8, pp. 1214–1223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Sun, A. Krishnan, K. Zaman, R. Lawrence, A. Bhattacharya, and G. Fernandes, “Dietary n‐3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice,” Journal of Bone and Mineral Research, vol. 18, no. 7, pp. 1206–1216, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. A. E. Barden, M. Moghaddami, E. Mas, M. Phillips, L. G. Cleland, and T. A. Mori, “Specialised pro-resolving mediators of inflammation in inflammatory arthritis,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 107, pp. 24–29, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Isobe, M. Arita, S. Matsueda et al., “Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid,” The Journal of Biological Chemistry, vol. 287, no. 13, pp. 10525–10534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Wan, C. Godson, P. J. Guiry, B. Agerberth, and J. Z. Haeggstrom, “Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1,” The FASEB Journal, vol. 25, no. 5, pp. 1697–1705, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Muruganandan, A. A. Roman, and C. J. Sinal, “Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells,” Journal of Bone and Mineral Research, vol. 25, no. 2, pp. 222–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. Proudman, M. J. James, L. D. Spargo et al., “Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use,” Annals of the Rheumatic Diseases, vol. 74, no. 1, pp. 89–95, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. A. J. Walton, M. L. Snaith, M. Locniskar, A. G. Cumberland, W. J. Morrow, and D. A. Isenberg, “Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 50, no. 7, pp. 463–466, 1991. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Belluzzi, C. Brignola, M. Campieri, A. Pera, S. Boschi, and M. Miglioli, “Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease,” The New England Journal of Medicine, vol. 334, no. 24, pp. 1557–1560, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Mozaffarian and J. H. Y. Wu, “(n-3) fatty acids and cardiovascular health: are rffects of EPA and DHA shared or complementary?” The Journal of Nutrition, vol. 142, no. 3, pp. 614S–625S, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. L. G. Cleland, M. J. James, and S. M. Proudman, “Fish oil: what the prescriber needs to know,” Arthritis Research & Therapy, vol. 8, no. 1, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. T. S. Orchard, X. Pan, F. Cheek, S. W. Ing, and R. D. Jackson, “A systematic review of omega-3 fatty acids and osteoporosis,” The British Journal of Nutrition, vol. 107, pp. S253–S260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Yuan, M. Akiyama, K. Nakahama, T. Sato, H. Uematsu, and I. Morita, “The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro,” Prostaglandins & Other Lipid Mediators, vol. 92, no. 1-4, pp. 85–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Van Dyke, S. Offenbacher, B. Pihlstrom, M. S. Putt, and C. Trummel, “What is gingivitis? Current understanding of prevention, treatment, measurement, pathogenesis and relation to periodontitis,” Journal of the International Academy of Periodontology, vol. 1, pp. 3–12, 1999. View at Google Scholar
  47. G. Weissmann, J. E. Smolen, and H. M. Korchak, “Release of inflammatory mediators from stimulated neutrophils,” The New England Journal of Medicine, vol. 303, no. 1, pp. 27–34, 1980. View at Publisher · View at Google Scholar · View at Scopus
  48. K. El Kholy, M. Freire, T. Chen, and T. E. Van Dyke, “Resolvin E1 promotes bone preservation under inflammatory conditions,” Frontiers in Immunology, vol. 9, 2018. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Hasturk, R. Abdallah, A. Kantarci et al., “Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 5, pp. 1123–1133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Gyurko and T. E. Van Dyke, “The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation,” Critical Reviews in Immunology, vol. 34, no. 4, pp. 347–357, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Funaki, Y. Hasegawa, R. Okazaki et al., “Resolvin E1 inhibits osteoclastogenesis and bone resorption by suppressing IL-17-induced RANKL expression in osteoblasts and RANKL-induced osteoclast differentiation,” Yonago Acta Medica, vol. 61, no. 1, pp. 8–18, 2018. View at Publisher · View at Google Scholar